Loading viewer...
earnings
Format: PDF earnings
Judges Scientific presented interim results for the six months ended 30 June 2024, highlighting its buy-and-build strategy in the scientific instrument market with 25 acquisitions since 2005 and strong organic revenue growth of 8% CAGR. The company demonstrated execution across three pillars of shareholder value creation: M&A, long-term drivers, and capital efficiency, with 28% CAGR total EBIT and 11% CAGR organic EBIT.
earnings
67 Pages
Deutsche Post DHL Group
Alembic Pharmaceuticals Q3 FY26 Investor Presentation
earningsearnings
20 Pages
Alembic Pharmaceuticals
Valmont Industries Q2 2016 Earnings Call Presentation
earningsearnings
18 Pages
Valmont Industries, Inc.